Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia.
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia.
J Control Release. 2022 Jul;347:314-329. doi: 10.1016/j.jconrel.2022.04.042. Epub 2022 May 13.
Scleral photocrosslinking is increasingly investigated for treatment of myopia and glaucoma. In this study a computational model was developed to predict crosslinking efficiency of visible/near infrared photosensitizers in the sclera. Photocrosslinking was validated against riboflavin corneal crosslinking experimental studies and subsequently modeled for the sensitizer, methylene blue, administered by retrobulbar injection to the posterior sclera and irradiated with a transpupillary light beam. Optimal ranges were determined for treatment parameters including light intensity, methylene blue concentration, injection volume, and inspired oxygen concentration. Additionally, sensitivity of crosslinking to various parameters was quantified. The most sensitive parameters were oxygen concentration in the injection solution, scleral thickness, and injection reservoir thickness (i.e., injection volume).
巩膜光交联术越来越多地被用于治疗近视和青光眼。在这项研究中,开发了一个计算模型来预测巩膜中可见/近红外光敏剂的交联效率。光交联作用通过核黄素角膜交联实验研究进行了验证,随后对敏化剂亚甲蓝进行了建模,亚甲蓝通过球后注射到后巩膜,并通过瞳孔光照射进行辐照。确定了包括光强度、亚甲蓝浓度、注射体积和吸入氧气浓度在内的治疗参数的最佳范围。此外,还量化了交联对各种参数的敏感性。最敏感的参数是注射溶液中的氧浓度、巩膜厚度和注射储液器厚度(即注射体积)。